FDA’s Decision to Approve New Treatment for Alzheimer’s Disease December 1, 2022 AutoBot News 0 FDA approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans, using the Accelerated Approval pathway